Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology In The News / Dan Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology Read More »
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023? In The News / Dan What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023? Read More »
Managing Raw Material Variability for Autologous Cell Therapies In The News / Dan Managing Raw Material Variability for Autologous Cell Therapies Read More »
Rare disease drug development needs regulatory incentives to grow in 2024 In The News / Dan Rare disease drug development needs regulatory incentives to grow in 2024 Read More »
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong? In The News / Dan What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong? Read More »
How is an increased focus on patient-centric concerns influencing the way that you work? In The News / Dan How is an increased focus on patient-centric concerns influencing the way that you work? Read More »
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning? In The News / Dan In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning? Read More »
BoB@JPM: Self-Replicating RNA With Elixirgen’s Akihiro Ko In The News / Dan BoB@JPM: Self-Replicating RNA With Elixirgen’s Akihiro Ko Read More »
A Next-Generation RNA Therapy Targets Telomere Disorders In The News / Dan A Next-Generation RNA Therapy Targets Telomere Disorders Read More »
Using Self-Replicating RNA Technology to Treat Telomere Biology Disorders with Akihiro Ko Elixirgen Therapeutics In The News / Dan Using Self-Replicating RNA Technology to Treat Telomere Biology Disorders with Akihiro Ko Elixirgen Therapeutics Read More »
